In a University of Oregon laboratory, scientists have achieved one of the most dramatic lifespan extensions ever recorded in an animal—446 percent in male roundworms—by silencing a single molecular signaling pathway. The discovery, published in the journal Aging in 2026, reveals that sex and tissue identity profoundly shape how an organism responds to the same genetic intervention, challenging the long-held assumption that longevity pathways operate uniformly across bodies. Perhaps most instructively, the work reminds us that living longer and living well are not the same promise, and that bio
Blocking insulin signaling extends male worm lifespan by 446%, study finds
Extending life does not necessarily preserve all aspects of physiological function.
Mark
So they turned off insulin signaling in male worms and the lifespan went up 446 percent. That's a huge number. Is that actually real, or is it one of those lab results that doesn't mean much?
Mimi
It's real in the sense that the measurement is accurate—they watched the worms age and recorded when they died. But you're right to be skeptical about what it means. These are tiny worms in a controlled environment. The point isn't that humans will live 446 percent longer if we suppress insulin. The point is that sex matters in ways aging research hasn't fully explored.
Luke
And we should note: this is a 446 percent increase in median lifespan. That's a specific statistical measure. Some individual worms lived even longer, some died sooner. The median is the middle value, so half the treated males lived longer than 106 days, half shorter. It's not that every worm got 446 percent longer.
Mark
Okay, so the sex difference is the real story. Males responded much more dramatically than hermaphrodites to the same genetic change. Why would that be?
Mimi
That's what the researchers are asking too. They don't have a complete answer yet. But they found that when you target the same pathway in different tissues, the effects flip. In the germline—the reproductive tissue—blocking the pathway actually shortened male lifespan by 19 percent. In hermaphrodites, it extends life. Same pathway, opposite direction.
Luke
Which means we're looking at a sex-specific biological difference, not just a difference in degree. The mechanism is different. That's important because it means you can't just study one sex and assume the results generalize.
Mark
And the healthspan part—they didn't just measure how long the worms lived, they measured whether they could still reproduce. That seems like a more meaningful measure of aging.
Mimi
Exactly. Mating requires a lot of coordinated function—muscles, nerves, reproductive organs all working together. It normally falls apart quickly as worms age. In the treated males, reproductive capacity persisted much longer. But here's the catch: when they targeted just the intestine, lifespan went up but reproductive health didn't improve. You need the whole-body effect to get both.
Luke
So extending lifespan and extending healthspan are not the same thing. You can make an organism live longer without making it live better. That's a crucial distinction that doesn't always get attention in aging research.
Mark
Does this change anything about how we should think about aging in humans?
Mimi
It suggests that sex-specific biology is more important than we've accounted for. Most aging studies have focused on one sex or treated sex as a variable to control for rather than something fundamental. This work says: sex shapes how organisms respond to interventions. That's worth taking seriously in human research too.
Luke
Though we should be clear: this is C. elegans. The insulin pathway is conserved across animals, which is why the work is interesting. But worms are not tiny humans. The dramatic lifespan extension here doesn't predict what would happen in people. It's a proof of concept that sex matters, not a roadmap for human intervention.
O Pulso
- Male C. elegans with a disabled insulin receptor lived to 106 days instead of the usual 15—a 446% extension that dwarfs nearly every single-gene longevity intervention on record.
- The same manipulation applied to hermaphrodites produced only a 109% gain, exposing a deep biological fault line between sexes that researchers had not fully anticipated.
- Tissue-by-tissue targeting revealed a troubling asymmetry: silencing the pathway in the intestine extended male life by 69%, but silencing it in the germline cut life short by 19%—the opposite of what occurs in hermaphrodites.
- Longer life did not automatically mean better life; only whole-body intervention preserved reproductive function, while intestine-only treatment extended survival without maintaining the worm's ability to mate.
- The team identified a newly recognized aging marker—a stiffening of the male tail that disrupts mating—and showed that whole-body treatment reduced it by more than 70% in younger-old males, linking molecular longevity to functional healthspan.
- Researchers caution against direct translation to human medicine, but the findings sharpen a critical principle: any serious theory of aging must account for sex-specific and tissue-specific variation in how longevity pathways operate.
In a University of Oregon laboratory, scientists have achieved one of the most dramatic lifespan extensions ever recorded in an animal—446 percent in male roundworms—by silencing a single molecular signaling pathway. The discovery, published in the journal Aging in 2026, reveals that sex and tissue identity profoundly shape how an organism responds to the same genetic intervention, challenging the long-held assumption that longevity pathways operate uniformly across bodies. Perhaps most instructively, the work reminds us that living longer and living well are not the same promise, and that biology rarely offers a single key to unlock both.
At the University of Oregon, a research team led by Rose Al-Saadi, Hannah Lewack, and Patrick Phillips set out to understand how male Caenorhabditis elegans age—and found something few longevity researchers had anticipated. By using a precise molecular tool to destroy the DAF-2 receptor, the protein through which insulin signals are received, they extended male worm lifespan by 446 percent. Animals that normally died around 15 days survived to 106. It stands among the largest lifespan extensions ever achieved through a single genetic intervention in any animal.
The sex of the worm mattered enormously. When the identical manipulation was applied to hermaphrodites, the lifespan gain was only 109 percent—substantial, but a fraction of the male response. This divergence signaled that the insulin signaling pathway does not operate the same way in all bodies, even within the same species.
The team pushed further, asking not just how long the worms lived but how well. They tracked mating success in aging males—a demanding measure, since successful reproduction requires coordinated muscles, intact anatomy, and a functioning nervous system. In treated males, reproductive capacity persisted far into later life, with the maximum mating age effectively doubling. The researchers also identified a previously unrecognized aging marker: a stiffening of the male tail that disrupts the precise behavioral sequence needed for mating. Whole-body treatment reduced this phenotype by more than 70 percent in younger-old males.
Tissue-specific experiments complicated the picture further. Targeting DAF-2 degradation to the intestine alone extended male lifespan by 69 percent, but targeting the germline shortened it by 19 percent—the reverse of what germline manipulation does in hermaphrodites. Neuronal and skin targeting had no significant effect. The pathway's influence on longevity was entirely contingent on which tissue was modified and which sex the animal was.
The gap between lifespan and healthspan proved to be the study's most instructive finding. Intestine-specific intervention prolonged survival without preserving reproductive function. Only the whole-body approach maintained both. The researchers conclude that extending how long an organism lives and extending how well it functions are governed by different tissue interactions—and that a single longevity intervention cannot be assumed to improve all dimensions of aging simultaneously. For a field still searching for universal principles, that distinction may be as important as the record-breaking numbers themselves.
In a laboratory at the University of Oregon, researchers have discovered something striking about how male worms age. When they disabled a single molecular pathway—the insulin and insulin-like growth factor signaling system, or IIS—the lifespans of male Caenorhabditis elegans stretched to extraordinary lengths. The median lifespan jumped by 446 percent. Males that normally lived about 15 days survived to 106 days. It is among the largest lifespan extensions ever achieved in any animal through a single genetic intervention.
The work, published in August 2026 in the journal Aging, emerged from a collaboration between Rose Al-Saadi, Hannah Lewack, and Patrick Phillips. The team used a precise molecular tool called an auxin-inducible degron system to selectively destroy the DAF-2 receptor—the protein that receives insulin signals—throughout the bodies of male worms. The results were dramatic and unexpected. When the same intervention was applied to hermaphroditic worms, the lifespan increase was only 109 percent. The sex of the animal fundamentally changed how it responded to the same genetic disruption.
But the researchers did not stop at measuring how long the worms lived. They asked a harder question: did they live better? To answer this, they tracked mating success in aging males. Mating in C. elegans is not simple—it requires coordinated muscle function, intact reproductive organs, and a functioning male-specific nervous system. It normally declines sharply with age. In treated males, however, reproductive capacity persisted into later life. The maximum age at which males could successfully mate effectively doubled. The team also discovered a previously unrecognized sign of aging in male worms: a stiffening or immobilization of the tail that interferes with the precise behavioral sequence needed for reproduction. Whole-body DAF-2 degradation reduced this "uncoordinated tail" phenotype by more than 70 percent in young-old males and by nearly 64 percent in older ones.
Yet the tissue-specific results revealed something more complex. When the researchers targeted DAF-2 degradation to just the intestine, male lifespan extended by 69 percent—substantial, but far less than the whole-body effect. Targeting the germline, the reproductive tissue, actually shortened male lifespan by 19 percent. This was the opposite of what happens in hermaphrodites, where germline manipulation extends life. Degrading DAF-2 in neurons or skin had no significant effect on survival. The pathway's influence on longevity, it turned out, depended entirely on which tissue was being modified and which sex the animal was.
The disconnect between lifespan and healthspan proved instructive. Intestine-specific DAF-2 degradation prolonged life but did not preserve reproductive health. Only the whole-body intervention maintained both. This suggests that extending how long an organism lives and extending how well it functions are separate problems, governed by different tissue interactions. The researchers note that the reproductive benefits required coordinated effects across multiple physiological systems—a finding that challenges the assumption that a single longevity intervention will improve all aspects of aging.
The team is careful about what these results mean beyond the laboratory. C. elegans is a powerful model for understanding conserved mechanisms of aging, but the 446 percent lifespan extension should not be read as evidence that suppressing insulin signaling in humans would produce comparable gains. The worms are useful precisely because they reveal how sex and tissue identity can reshape responses to the same molecular pathway. The findings underscore an emerging principle in aging research: that males and females, and different tissues within the same organism, can respond in fundamentally different ways to interventions targeting well-established longevity pathways. Future work will need to account for this biological variation if researchers hope to understand aging across the full diversity of living systems.
Citações Notáveis
Genetic interventions targeting the IIS pathway extend not only male lifespan, but also their reproductive healthspan.— Research team statement
Males represent a useful tool for future aging research, as they may be more susceptible to certain interventions and provide a complex behavioral context that can be used to assess the efficacy of interventions on reproductive healthspan.— Patrick Phillips and colleagues
Quer a matéria completa?
Leia o original em EurekAlert! ↗
Science & Space